WORMTAC

This brand name is authorized in Nigeria.

Active ingredients

The drug WORMTAC contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-1292	Tablet	WORMTAC TABLETS TAB 400 mg 1 X 1	58 CMS-PP-372917 WORMTAC TABLETS ALBENDAZOLE USP 400MG ALBENDAZOLE USP 400MG lactose, maize starch, PVP K-30. Sodium benzoate, talcum, aspartame, sodium starch glycolate, raspberry flavour, Magnesium stearate A4-1292 Drugs Imported Products 1x1tablet Prescription Only Medicine (POM) 11/5/2023 MAYDON PHARMACEUTICAL LIMITED., WILMER STREET, OFF TOWN PLANNING, ILUPEJU, LAGOS LAGOS 1740194511 maydonp@outlook.com MAXHEAL LABORATORIES PVT LTD, PLOT NO. 2-7/80-85 SURSEZ SACHIN DIST. SURAT GUJARAT 394 230 INDIA, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-1292